Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 128 participants.
Also called NCT01499407
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 128 participants
- Sponsor
- CLI Foundation
- Registry
-
NCT01499407
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01499407. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction
- Acronym
- COCTAIL II
- Condition
- ST-elevation Myocardial Infarction
- Intervention (Device)
- ClearWay RX catheter
- Intervention (Drug)
- Abciximab
- Lead sponsor
- CLI Foundation
Record details
- Record id
cardio:ct-nct01499407- Content hash
e44150849a592aa4beb353865f95444d6047b097635e51af42287a5e8f743027